Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2007
04/19/2007WO2004081527A3 Systems for differential ion mobility analysis
04/19/2007WO2004080392A3 Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth
04/19/2007WO2004072588A3 Multiphase coriolis flowmeter
04/19/2007US20070088525 Method and System for Representation of Current and Historical Medical Data
04/19/2007US20070088513 Producing system and its control device, control method, control system and control program
04/19/2007US20070088510 Method and system for faster and more sensitive homology searching
04/19/2007US20070088155 siRNA targeting tumor necrosis factor superfamily member 1A
04/19/2007US20070088154 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing
04/19/2007US20070088153 siRNA targeting BCL2L1
04/19/2007US20070088152 siRNA targeting KRAS
04/19/2007US20070088151 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/19/2007US20070088054 Biphenyl derivatives
04/19/2007US20070088003 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
04/19/2007US20070087984 Method of identifying agents that inhibit the growth of cancer cells
04/19/2007US20070087983 Novel ubp8rp polypeptides and their use in the treatment of psoriasis
04/19/2007US20070087967 Methods and compositions for inhibiting angiogenesis
04/19/2007US20070087964 Novel compositions and methods for modulating the acid-sensing ion channel (asic)
04/19/2007US20070087453 Immuno conjugate and process for preparation thereof
04/19/2007US20070087452 Luminescent lanthanide complexes
04/19/2007US20070087451 Immuno-gold lateral flow assay
04/19/2007US20070087450 Immuno-gold lateral flow assay
04/19/2007US20070087446 Aromatic phosphonium salts and their use as labeling reagents in mass spectrometry analysis
04/19/2007US20070087443 Indicator
04/19/2007US20070087441 2,3-Bis-[3-(cyano-dimethyl-methyl)-5-methyl-phenyl]-2-methyl-propionitrile (impurity A); HPLC method used to determine the presence of impurity A in a 5-bis(2-cyanoisopropyl)toluene sample
04/19/2007US20070087440 Rapid serum sugar biomarker assay of rheumatoid arthritis
04/19/2007US20070087439 Method of measuring hexavalent chromium in electronic components and assemblies
04/19/2007US20070087427 Crystal structure of a deacetylase and inhibitors thereof
04/19/2007US20070087414 Uses of human Zven proteins and polynucleotides
04/19/2007US20070087412 Metalloprotease-disintegrin ADAM23 (SVPH3-17)
04/19/2007US20070087407 Hepatitis C receptor protein CD81
04/19/2007US20070087396 Method of tacrolimus extraction and quantification using aqueous detergents
04/19/2007US20070087395 Method for detecting pathogenic organisms in fecal and salivary specimens and in biopsy material
04/19/2007US20070087394 determining the EGFr gene copy number in a colorectal sample from a patient, wherein the presence of an increased EGFr gene copy number in the sample predicts that an anti-EGFr monoclonal antibody ( panitumumab) will be efficacious in treating colorectal cancer in the patient; drug screening
04/19/2007US20070087393 for predicting the prognosis of chronic lymphocytic leukemia (CLL); malignancy of bone marrow cells; increased reliability, sensitivity and greater quantitative precision
04/19/2007US20070087392 Method for diagnosing head and neck squamous cell carcinoma
04/19/2007US20070087391 Optoelectronic sensor
04/19/2007US20070087390 Opiate, cannabinoid, and estrogen receptors
04/19/2007US20070087389 Control system using immune network and control method
04/19/2007US20070087388 G protein coupled receptor
04/19/2007US20070087387 Method for the Early Detection of Renal Disease Using Proteomics
04/19/2007US20070087386 Observing in serum specimens concentration and change of alpha 1-antitrypsin, and comparing with a predetermined baseline level of the biochemical marker contained in serum; statistical analysis can be performed to evaluate the baseline level indicating the occurrence of endometriosis
04/19/2007US20070087385 Spherical and magnetical silicagel carriers having an increase surface for purifying nucleic acids
04/19/2007US20070087384 Indentifying analytes which interfere with the interaction between the cDkk-4 protein and a homologous or heterologous Dkk receptor; useful for treating osteoporosis and other bone loss disorders.
04/19/2007US20070087383 Immunoassay
04/19/2007US20070087380 Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
04/19/2007US20070087377 Methods and compositions for reverse translation
04/19/2007US20070087375 Methods and compositions for treating cancer using 2192, 2193, 6568, 8895, 9138, 9217, 9609, 9857, 9882, 10025, 20657, 21163, 25848, 25968, 32603, 32670, 33794, 54476 and 94710
04/19/2007US20070087372 Isolated ductal fluid sample
04/19/2007US20070087365 Methylation markers for diagnosis and treatment of ovarian cancer
04/19/2007US20070087361 Determining which allele is present in a sample tot reduce non-specific hybridization or reduce the impact of non-specific hybridization on the assay by using oligonucleotides having at least on non-standard base (iscytosine and isoguanine); kits
04/19/2007US20070087357 Lateral flow device with onboard reagents
04/19/2007US20070087352 Inhibitors for androgen antagonist refractory prostate cancer
04/19/2007US20070087351 Orotate transporter encoding maker genes
04/19/2007US20070087348 System and method for carrying out multiple binding reactions in an array format
04/19/2007US20070087346 Orthogonal gene switches
04/19/2007US20070087344 Methods for characterizing signaling pathways and compounds that interact therewith
04/19/2007US20070087342 Secreted proteins
04/19/2007US20070087333 Method to detect antigen-specific cytolytic activity
04/19/2007US20070087331 Selection of b cells with specificity if interest: method of preparation and use
04/19/2007US20070087330 Viral deconstruction through capsid assembly in vitro
04/19/2007US20070087325 Method of screening for cell colonies that express a soluble variant of a target protein
04/19/2007US20070087323 Sampling system
04/19/2007US20070087114 Microstamping activated polymer surfaces
04/19/2007US20070087037 Stimulation of cpt-1 as a means to reduce weight
04/19/2007US20070087018 Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis, compositions containing same and methods of use thereof
04/19/2007US20070087008 Rab9a, rab11a, and modulators thereof related to infectious disease
04/19/2007US20070087007 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
04/19/2007US20070087004 Pro104 antibody compositions and methods of use
04/19/2007US20070086994 Anti-nik antibodies and uses thereof
04/19/2007US20070086950 GAT2 transporters expressed in blood brain barrier cells
04/19/2007US20070086942 Methods and compositions for generating bioactive assemblies of increased complexity and uses
04/19/2007US20070086929 Method of manufacturing a sensor dispensing instrument having a modular electronics assembly
04/19/2007US20070086926 Functional unit enabling controlled flow in a microfluidic device
04/19/2007US20070086918 Cytometer
04/19/2007US20070086917 Automated molecular pathology apparatus having fixed slide platforms
04/19/2007US20070086625 Drug authentication
04/19/2007US20070085996 Blood Processing Apparatus with Dedicated Stroboscopic Controller for LED Source
04/19/2007US20070085995 Wearable glucometer
04/19/2007US20070084734 Methods for measuring physiological fluids
04/19/2007US20070084722 Water quality analyzer
04/19/2007US20070084303 Method and apparatus for testing materials
04/19/2007US20070084301 Bound materials core measuring device
04/19/2007US20070084295 Displacement-measuring apparatus and power-measuring apparatus
04/19/2007US20070084271 Method and apparatus for estimating basicity of a used, all-loss cylinder lubricant
04/19/2007US20070083977 Magnetically Detectable Latex Articles
04/19/2007DE202006019862U1 Testmischung Test mixture
04/19/2007DE19749012B4 Verfahren und Vorrichtung zum kontinuierlichen Nachweis von heteroatomhaltigen organischen Verbindungen, die in einer gasförmigen Phase vorliegen Method and apparatus for continuous monitoring the presence of heteroatom-containing organic compounds present in a gaseous phase
04/19/2007DE10206710B4 Vorrichtung zum Messen von Probeneigenschaften bei Dauerschwingversuchen Apparatus for measuring sample properties in fatigue tests
04/19/2007DE102006044502A1 Vorrichtung und Verfahren zum Schätzen der Fahrzeugkraftstoffzusammensetzung Apparatus and method for estimating vehicle fuel composition
04/19/2007DE102005049888A1 Device for carrying out dosing, mixing, sample-taking and measuring processes used in biotechnology and in chemistry comprises a pump for supplying dosing, sampling, reactor and sensor paths
04/19/2007DE102005049220A1 Testing decay time of solid test specimens in liquids involves triggering signal for full dissolution of test object and passing to control and evaluation unit when tip of test rod touches test tube bottom
04/19/2007DE102005048899A1 Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen Method for the diagnosis of thromboembolic disease and coronary heart disease
04/19/2007DE102005048184A1 Method for rapidly testing the quality of cereals, grits and flour by measuring the aggregation of gluten comprises stirring the test sample in aqueous solution/suspension with mineral salts, acids and/or liquors and further processing
04/19/2007DE102005040872B3 Collecting samples, especially of marine algae for implant production, comprises sealing or not sealing a transport container on the basis of global positioning data
04/19/2007DE10196488B4 Feststellung und Messung niedriger Pegel von Bor Detection and measurement of low levels of boron
04/19/2007CA2672322A1 Method for detecting a biomarker of oxidative stress in a biological sample
04/19/2007CA2639119A1 Agent for preventing/treating cancer
04/19/2007CA2626669A1 Methods for indentification of inhibitors of enzyme activity
04/19/2007CA2626023A1 Modulators of nod1 signaling
04/19/2007CA2625993A1 Interleukin-8 labelled via one or more site specifically conjugated hydrazinonicotinamide (hynic) moieties and its use in diagnosis of infection and inflammation